Your account is not claimed yet. You can sign up with ORCID to claim your account.

Peter Cuthbertson

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Venues

Immunology and cell biology

Purinergic signalling

Methods in molecular biology (Clifton, N.J.)

International journal of molecular sciences

University of Wollongong (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Wollongong

Australia

PHD :: School of Chemistry and Molecular Bioscience

Publications

Chloe Sligar, Peter Cuthbertson, Nicole A Miles, Sam R Adhikary, Amal Elhage, Geoff Zhang, Stephen I Alexander, Ronald Sluyter, Debbie Watson
Tocilizumab increases regulatory T cells, reduces natural killer cells and delays graft-versus-host disease development in humanized mice treated with post-transplant cyclophosphamide. Immunology and cell biology (2023)
Chloe Sligar, Peter Cuthbertson, Nicole A Miles, Sam R Adhikary, Amal Elhage, Geoff Zhang, Stephen I Alexander, Ronald Sluyter, Debbie Watson
Tocilizumab increases regulatory T cells, reduces natural killer cells and delays graft-versus-host disease development in humanized mice treated with post-transplant cyclophosphamide. Immunology and cell biology (2023)
Peter Cuthbertson, Amal Elhage, Dena Al-Rifai, Reece A Sophocleous, Ross J Turner, Ashraf Aboelela, Hiwa Majed, Richard S Bujaroski, Iman Jalilian, Michael J Kelso, Debbie Watson, Benjamin J Buckley, Ronald Sluyter
6-Furopyridine Hexamethylene Amiloride Is a Non-Selective P2X7 Receptor Antagonist. Biomolecules 12 (9) (2022)
Amal Elhage, Chloe Sligar, Peter Cuthbertson, Debbie Watson, Ronald Sluyter
Insights into mechanisms of graft-versus-host disease through humanised mouse models. Bioscience reports 42 (9) (2022)
Peter Cuthbertson, Ronald Sluyter
The P2X7 receptor is a target of p53 and regulates haematopoiesis following radiation-induced genotoxic stress. Purinergic signalling (2022)
Debbie Watson, Sam R Adhikary, Peter Cuthbertson, Nicholas J Geraghty, Katrina M Bird, Amal Elhage, Chloe Sligar, Ronald Sluyter
Humanized Mouse Model to Study the P2X7 Receptor in Graft-Versus-Host Disease. Methods in molecular biology (Clifton, N.J.) 2510 (2022)
Amal Elhage, Ross J Turner, Peter Cuthbertson, Debbie Watson, Ronald Sluyter
Preparation of the Murine Anti-Human P2X7 Receptor Monoclonal Antibody (Clone L4). Methods in molecular biology (Clifton, N.J.) 2510 (2022)
Peter Cuthbertson, Nicholas J Geraghty, Sam R Adhikary, Katrina M Bird, Stephen J Fuller, Debbie Watson, Ronald Sluyter
Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host Disease. International journal of molecular sciences 22 (15) (2021)
Sam R Adhikary, Peter Cuthbertson, Leigh Nicholson, Katrina M Bird, Chloe Sligar, Min Hu, Philip J O'Connell, Ronald Sluyter, Stephen I Alexander, Debbie Watson
Post-transplant cyclophosphamide limits reactive donor T cells and delays the development of graft-versus-host disease in a humanized mouse model. Immunology 164 (2) (2021)
Diane Ly, Anjila Dongol, Peter Cuthbertson, Thomas V Guy, Nicholas J Geraghty, Reece Andrew Sophocleous, Lucia Sin, Bradley J Turner, Debbie Watson, Justin J Yerbury, Ronald Sluyter
The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1G93A mice. Purinergic signalling 16 (1) (2020)
Sam R Adhikary, Peter Cuthbertson, Ross J Turner, Ronald Sluyter, Debbie Watson
A single-nucleotide polymorphism in the human ENTPD1 gene encoding CD39 is associated with worsened graft-versus-host disease in a humanized mouse model. Immunology and cell biology 98 (5) (2020)

Peter Cuthbertson.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Peter Cuthbertson